CoChat

Tissue-specific, non-invasive toxicity biomarkers: translation from preclinical safety assessment to clinical safety monitoring

Muller, Patrick Y, Dieterle, Frank · 2009 · Expert Opinion on Drug Metabolism & Toxicology

The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.

Abstract

Limited sensitivity and limited target organ specificity are the major drawbacks for most peripheral clinical pathology parameters traditionally used for monitoring organ integrity both during preclinical toxicological assessment and clinical safety testing of investigational drugs. Several novel toxicity biomarkers have emerged as sensitive tools for detection, monitoring, quantification and prediction of solid organ toxicity. These tissue-specific, non-invasive biomarkers may provide valuable information for decision making during toxicological assessment and may be used for sensitive and specific target organ monitoring during clinical trials. This review critically discusses the opportunities and limitations of these biomarkers with respect to their translation into (first-in-human) clinical trials. A comprehensive overview is provided on serum- and urine-based biomarkers for hepatotoxicity, nephrotoxicity, cardiotoxicity, gonadotoxicity, pancreatic toxicity, vascular toxicity and phospholipidosis including species-specific assay availabilities and sampling regimens. In addition, the current regulatory status is presented and discussed in view of recent changes in regulatory acceptance by health authorities.

Overview

Integrity signals

Registry

Crossref · 10.1517/17425250903114174

Cites

81 of 81 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 81 references

Research works printed but not linked: 4

  1. Dieterle, 2008, Curr Opin Drug Discov Dev, 11, 60
  2. Bosch, 1995, Semin Nephrol, 15, 381
  3. Urbanova, 2006, Neoplasma, 53, 183
  4. Reisler, 2005, J Acquir Immune Defic Syndr, 39, 159

Cited by

See all 62

Metadata

Authors
Muller, P. Y., & Dieterle, F.
Affiliations
Novartis (Switzerland) (CH)
Venue
Expert Opinion on Drug Metabolism & Toxicology
Published
2009-07-17
Volume
5
Issue
9
Pages
1023-1038
ISSN
  • 1742-5255 (ISSN-L)
  • 1744-7607
OpenAlex
W2092612655
Cited by
62
References
81
Citations by year
2026: 3 · 2025: 2 · 2024: 3 · 2022: 3 · 2021: 1 · 2019: 3 · 2018: 1 · 2017: 4 · 2016: 4 · 2015: 3 · 2014: 2 · 2013: 12 · 2012: 9
FWCI
0.92
Type
journal article
Language
en
Open access
closed
Locations
  • Expert Opinion on Drug Metabolism & Toxicology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
  • Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
Keywords
biomarkers of toxicity, tissue-specific biomarkers, non-invasive biomarkers, pharmacovigilance, preclinical toxicology, clinical trials, hepatotoxicity, nephrotoxicity, cardiotoxicity, gonadotoxicity, pancreatic toxicity, vascular toxicity, phospholipidosis, serum biomarkers, urinary biomarkers, regulatory acceptance
MeSH terms
Animals, Clinical Trials as Topic, Drug Evaluation, Preclinical, Humans, Biomarkers, Drug Approval, Drug-Related Side Effects and Adverse Reactions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tissue-specific, non-invasive toxicity biomarkers: translation from preclinical safety assessment to clinical safety monitoring. https://app.cochat.ai/papers/10.1517/17425250903114174
The paper
Muller, P. Y., & Dieterle, F. (2009). Tissue-specific, non-invasive toxicity biomarkers: translation from preclinical safety assessment to clinical safety monitoring. Expert Opinion on Drug Metabolism & Toxicology. https://doi.org/10.1517/17425250903114174

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.